
Prasol Chemicals IPO
- Issue price
- ₹676
- Listing price
- ₹610
- -9.76%
- Current price
- ₹801.65
- +18.59%
- Subscribed
- 3.3x
- Issue size
- ₹500 Cr
- Listed on
- 16 Sep 2026
IPO timeline
- Opens8 SepTue
- Closes10 SepThu
- Allotment11 SepFri
- Refunds15 SepTue
- Demat credit15 SepTue
- Listing16 SepWed
Issue details
- Price band
- ₹643 – ₹676 per share
- Issue size
- ₹500 Cr
- Fresh issue
- Not available
- Offer for sale
- Not available
- Issue type
- Fresh capital cum OFS
- Face value
- ₹2 per share
- Lot size
- 22 shares
- Minimum investment
- ₹14,872
- Listing on
- BSE, NSE
- Exchange code
- PRASOLCHEM · 7947
This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 22 | ₹14,872 |
| Retail (Max) | 13 | 286 | ₹1,93,336 |
| S-HNI (Min) | 14 | 308 | ₹2,08,208 |
| B-HNI (Min) | 68 | 1,496 | ₹10,11,296 |
Reservation
- QIB
- Not more than 50% of the Offer
- Retail
- Not less than 35% of the Offer
- NII
- Not less than 15% of the offer
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on KFin Technologies- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 11 Sep 2026
- Refunds initiated
- 15 Sep 2026
- Shares credited to demat
- 15 Sep 2026
- Listing
- 16 Sep 2026
Grey market premium (GMP)
- Current GMP
- ₹-13
- -1.92%
- Estimated listing price
- ₹663
- Issue price ₹676
- Highest
- ₹165
- 4 Sep
- Lowest
- ₹-15
- 11 Sep
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 16 Sep 2026 | ₹-13 | -1.92% | ₹663 |
| 15 Sep 2026 | ₹-13 | -1.92% | ₹663 |
| 14 Sep 2026 | ₹-13 | -1.92% | ₹663 |
| 13 Sep 2026 | ₹-15 | -2.22% | ₹661 |
| 12 Sep 2026 | ₹-15 | -2.22% | ₹661 |
| 11 Sep 2026 | ₹-15 | -2.22% | ₹661 |
| 10 Sep 2026 | ₹4 | +0.59% | ₹680 |
| 9 Sep 2026 | ₹5 | +0.74% | ₹681 |
| 8 Sep 2026 | ₹30 | +4.44% | ₹706 |
| 7 Sep 2026 | ₹55 | +8.14% | ₹731 |
| 6 Sep 2026 | ₹115 | +17.01% | ₹791 |
| 5 Sep 2026 | ₹125 | +18.49% | ₹801 |
| 4 Sep 2026 | ₹165 | +24.41% | ₹841 |
| 3 Sep 2026 | ₹14 | +2.07% | ₹690 |
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB7.22x
- NII (HNI)1.8x
- Retail1.7x
| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 15,55,209 | 1,12,28,140 | 7.22x |
| Non-Institutional Investors (NII) | 11,66,406 | 20,95,302 | 1.8x |
| bNII — bids above ₹10 Lakh | 7,77,604 | 9,01,560 | 1.16x |
| sNII — bids ₹2 Lakh to ₹10 Lakh | 3,88,802 | 11,93,742 | 3.07x |
| Retail Individual Investors (RII) | 27,21,614 | 46,39,206 | 1.7x |
| Total | 54,43,229 | 1,79,62,648 | 3.3x |
Financials
- RoE
- 20.37%
- RoCE
- 22.43%
- RoNW
- 18.53%
- PAT Margin
- 6.74%
- EBITDA Margin
- 11.30%
- Debt / Equity
- 0.19
- NAV (₹)
- 77.33
| Period ended | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 839.28 | 723.09 | 626.36 |
| Total Income | 1,237.85 | 1,015.54 | 887.56 |
| Profit After Tax | 83.12 | 43.57 | 18.13 |
| EBITDA | 139.32 | 87.77 | 60.53 |
| NET Worth | 448.51 | 367.46 | 325.84 |
| Reserves and Surplus | 436.91 | 355.87 | 314.24 |
| Total Borrowing | 110.06 | 101.05 | 82.07 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Prasol Chemicals This IPO | ₹500 Cr | — | 18.53% | 6.74% | 3.3x | -9.76% |
| Gem Aromatics Mainboard · listed 26 Aug 2025 | ₹451.25 Cr | 31.8 | 18.80% | 10.56% | 30.45x | +2.49% |
| GSP Crop Science Mainboard · listed 24 Mar 2026 | ₹400 Cr | 15.34 | — | 9.56% | 1.64x | +2.81% |
| JNK India Mainboard · listed 30 Apr 2024 | ₹649.47 Cr | 37.46 | 31.79% | 18.24% | 28.46x | +49.64% |
| J.G. Chemicals Mainboard · listed 13 Mar 2024 | ₹251.19 Cr | 20.08 | 8.16% | 7.24% | 28.52x | -5.43% |
| Advance Agrolife Mainboard · listed 8 Oct 2025 | ₹193 Cr | 17.55 | 29.11% | 5.10% | 56.89x | +14.00% |
| Shanti Inorganics SME · listed 7 Sep 2026 | ₹47.24 Cr | 9.54 | 27.68% | 14.01% | 132.3x | +90.00% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Prasol Chemicals plans to use the money raised, as stated in the offer document.
- Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company₹60 Cr
- General Corporate Purposes
About Prasol Chemicals
Prasol Chemicals was started in 1992 and works in the specialty chemicals industry. Specialty chemicals are made in smaller quantities for a specific use, unlike bulk commodity chemicals. The company makes more than 150 different specialty chemicals. Its range covers 21 acetone based chemicals, 53 phosphorous based chemicals and 76 other products such as surfactants, esters and acids. These products go into five main industries. These are performance chemicals such as lubricant and mining additives, the group known as PICA which covers paint, inks, construction and adhesives, pharmaceuticals, agrochemicals, and home and personal care. Its customers include Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science, Gharda Chemicals, Croda India, Supriya Lifescience and Yasho Industries. As on 31 July 2026 it served about 1,600 customers and exported to 69 countries, and it is certified as a 3 Star Export House by the Government of India. It runs two plants, at Khopoli covering 1,20,604 square metres and at Mahad covering 1,19,423 square metres, with a combined capacity of 98,644 tonnes a year.
Strengths
- Profit has grown more than four times in two years, from Rs 18.13 crore in FY2024 to Rs 43.57 crore in FY2025 and Rs 83.12 crore in FY2026.
- Sales have grown steadily, from Rs 887.56 crore in FY2024 to Rs 1,015.54 crore in FY2025 and Rs 1,237.85 crore in FY2026.
- EBITDA more than doubled over the same period, from Rs 60.53 crore to Rs 139.32 crore.
- The product range is very wide at more than 150 chemicals, spread across five different end industries, so it does not depend on one sector.
- The customer base is large and reputed, with about 1,600 customers including Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science and Croda India.
- It exports to 69 countries and is certified as a 3 Star Export House, with distribution across Asia Pacific, the Americas and Europe.
- It has a long record of more than 30 years and two plants with a combined capacity of 98,644 tonnes a year.
- RoCE was 22.43% and RoNW was 18.53% in FY2026.
Risks
- The P/E and EPS are not stated in the data available to us, so the issue cannot be compared with chemical peers on earnings from here.
- The profit margin is thin at 6.74%, which is low for a company describing itself as a specialty chemicals maker.
- Very little of the money is going into the business. Only Rs 60 crore of the Rs 500 crore issue is earmarked for repaying borrowings, with the rest to general corporate purposes and to the selling shareholders.
- Borrowing has gone up every year, from Rs 82.07 crore in FY2024 to Rs 101.05 crore in FY2025 and Rs 110.06 crore in FY2026.
- Raw material prices drive this business. Acetone and phosphorus feedstock are linked to crude and to global chemical cycles, and a sharp rise cannot always be passed on.
- Both plants are in Maharashtra, at Khopoli and Mahad, so there is regional concentration, and chemical plants carry pollution control and environmental compliance risk.
- Exporting to 69 countries brings currency risk and exposure to anti-dumping duties and trade rules in those markets.
- This is a fresh issue combined with an offer for sale, and promoter holding falls from 89.2% to 77.51% after the issue.
Promoters and shareholding
Nishith Rajnikant Shah, Gaurang Natwarlal Parikh, Dhaval Nalin Parikh, Pankil Nishith Dharia, Sachin Jatin Parikh, Rakesh Gupta, Nishith Rasiklal Dharia, Kunal Tushar Dharia, Suketu Navinchandra Parikh and Usha Rajnikant Shah
- Promoter holding, pre-issue
- 89.2%
- Promoter holding, post-issue
- 77.51%
Anchor investors
| Investor | Shares allotted | Amount | % of anchor book |
|---|---|---|---|
| KOTAK SPECIAL OPPORTUNITIES FUND | 1,17,898 | ₹7.97 Cr | 5.31% |
| KOTAK HEALTHCARE FUND | 1,17,876 | ₹7.97 Cr | 5.31% |
| KOTAK RURAL OPPORTUNITIES FUND | 60,104 | ₹4.06 Cr | 2.71% |
| TATA INDIA PHARMA & HEALTHCARE FUND | 1,47,950 | ₹10 Cr | 6.67% |
| TATA INDIA INNOVATION FUND | 1,47,928 | ₹10 Cr | 6.67% |
| ADITYA BIRLA SUN LIFE INSURANCE CO.LTD. | 2,95,878 | ₹20 Cr | 13.33% |
| TATA AIA LIFE INSURANCE CO.LTD.-SMALL CAP DISCOVERY FUND (ULIF 071 22/05/23 SCF 110) | 2,95,878 | ₹20 Cr | 13.33% |
| TURNAROUND OPPORTUNITIES FUND | 2,21,892 | ₹15 Cr | 10% |
| 360 ONE EQUITY OPPORTUNITY FUND-SERIES IV | 73,986 | ₹5 Cr | 3.33% |
| EDELWEISS AGGRESSIVE HYBRID FUND | 1,47,950 | ₹10 Cr | 6.67% |
| EDELWEISS RECENTLY LISTED IPO FUND | 44,374 | ₹3 Cr | 2% |
| ITI SMALL CAP FUND | 2,21,914 | ₹15 Cr | 10% |
| CLARUS CAPITAL I | 1,77,352 | ₹11.99 Cr | 7.99% |
| NUVAMA MULTI ASSET STRATEGY RETURN FUND | 1,47,950 | ₹10 Cr | 6.67% |
Registrar, lead managers and documents
Lead manager
Company contact
Prasol House, Plot No A - 17/2/3, T. T. C, Industrial Area, Khairne M.I.D.C., Navi Mumbai, Thane, Maharashtra, 400710
+91 22 6195 2500
investorservices@prasolchem.comPrasol Chemicals IPO: common questions
1.When does the Prasol Chemicals IPO open and close?
The Prasol Chemicals IPO opens on 8 Sep 2026 and closes on 10 Sep 2026.
2.What is the price band of the Prasol Chemicals IPO?
The price band is ₹643 – ₹676 per share, with a lot size of 22 shares and a minimum investment of ₹14,872.
3.What is the size of the Prasol Chemicals IPO?
The issue size is ₹500 Cr (Fresh capital cum OFS).
4.What is the GMP of the Prasol Chemicals IPO?
The last reported grey market premium is ₹-13 per share as of 16 Sep 2026, 08:24 AM IST. GMP is unofficial and changes frequently.
5.When is the Prasol Chemicals IPO allotment?
The basis of allotment is expected on 11 Sep 2026. Allotment status can be checked with the registrar, KFin Technologies Limited.
6.When will the Prasol Chemicals IPO list?
The shares listed on 16 Sep 2026 on BSE, NSE.
7.Who is the lead manager of the Prasol Chemicals IPO?
The book running lead manager is Dam Capital Advisors Ltd, and the registrar is KFin Technologies Limited.
8.What will the money raised in the Prasol Chemicals IPO be used for?
As stated in the offer document, the proceeds are for: Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company; General Corporate Purposes.
9.How can my company launch an IPO like Prasol Chemicals?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393